Hangzhou AGS MedTech Statistics
Total Valuation
SHA:688581 has a market cap or net worth of CNY 4.64 billion. The enterprise value is 2.91 billion.
| Market Cap | 4.64B |
| Enterprise Value | 2.91B |
Important Dates
The next confirmed earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Jul 9, 2025 |
Share Statistics
SHA:688581 has 80.72 million shares outstanding. The number of shares has decreased by -0.18% in one year.
| Current Share Class | 80.72M |
| Shares Outstanding | 80.72M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | -3.64% |
| Owned by Insiders (%) | 7.18% |
| Owned by Institutions (%) | 7.33% |
| Float | 55.19M |
Valuation Ratios
The trailing PE ratio is 20.77 and the forward PE ratio is 11.62.
| PE Ratio | 20.77 |
| Forward PE | 11.62 |
| PS Ratio | 7.78 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 1.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.04 |
| EV / Sales | 4.87 |
| EV / EBITDA | 10.65 |
| EV / EBIT | 10.97 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.12% and return on invested capital (ROIC) is 29.82%.
| Return on Equity (ROE) | 9.12% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 29.82% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.31% |
| Revenue Per Employee | 802,698 |
| Profits Per Employee | 299,485 |
| Employee Count | 856 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHA:688581 has paid 41.10 million in taxes.
| Income Tax | 41.10M |
| Effective Tax Rate | 15.57% |
Stock Price Statistics
The stock price has decreased by -17.36% in the last 52 weeks. The beta is 0.38, so SHA:688581's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -17.36% |
| 50-Day Moving Average | 61.16 |
| 200-Day Moving Average | 66.41 |
| Relative Strength Index (RSI) | 35.21 |
| Average Volume (20 Days) | 431,480 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688581 had revenue of CNY 597.21 million and earned 222.82 million in profits. Earnings per share was 2.77.
| Revenue | 597.21M |
| Gross Profit | 597.21M |
| Operating Income | 264.82M |
| Pretax Income | 263.92M |
| Net Income | 222.82M |
| EBITDA | 272.79M |
| EBIT | 264.82M |
| Earnings Per Share (EPS) | 2.77 |
Balance Sheet
The company has 1.74 billion in cash and 2.58 million in debt, giving a net cash position of 1.74 billion or 21.54 per share.
| Cash & Cash Equivalents | 1.74B |
| Total Debt | 2.58M |
| Net Cash | 1.74B |
| Net Cash Per Share | 21.54 |
| Equity (Book Value) | 2.49B |
| Book Value Per Share | 30.58 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 44.34% and 37.31%.
| Gross Margin | 100.00% |
| Operating Margin | 44.34% |
| Pretax Margin | 44.19% |
| Profit Margin | 37.31% |
| EBITDA Margin | 45.68% |
| EBIT Margin | 44.34% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.37, which amounts to a dividend yield of 2.36%.
| Dividend Per Share | 1.37 |
| Dividend Yield | 2.36% |
| Dividend Growth (YoY) | -5.28% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.18% |
| Shareholder Yield | 2.55% |
| Earnings Yield | 4.80% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 21, 2024. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 21, 2024 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |